Mary White,Hannah Han,Vandana Khungar
Mary White
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines [0.03%]
红细胞生成性卟啉病和X连锁卟啉病中与原卟啉相关的肝功能障碍的诊断和管理：2023年基于证据共识指南的患者友好型摘要
Anna K Mann,Liz Allan,Kristen P Wheeden et al.
Anna K Mann et al.
Proper assessment and prognostication of patients with hepatocellular carcinoma [0.03%]
肝细胞癌患者的有效评估及预后判断
Edoardo G Giannini
Edoardo G Giannini
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challenges [0.03%]
亚太地区实现乙型肝炎病毒学应答的现状和挑战
Jing Chen,George Lau
Jing Chen
Alejandro Torres-Hernandez,Patrick G Northup
Alejandro Torres-Hernandez
Rebecca Roediger,Jaquelyn Fleckenstein
Rebecca Roediger
Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes [0.03%]
与代谢功能障碍相关的脂肪肝疾病：不良妊娠结局的新兴风险因素
Georgia Sofia Karachaliou,Ayako Suzuki
Georgia Sofia Karachaliou
Epidemiology and health care burden of autoimmune liver diseases in Mexico [0.03%]
墨西哥自身免疫性肝病的流行病学和医疗负担
Jose C Cessa-Zanatta,Carlos A Cortez-Hernández,Daniela Goyes et al.
Jose C Cessa-Zanatta et al.
Meera Garriga,Grace Zhang,Monika Sarkar
Meera Garriga
1_ov26k0cyKaltura. Copyright © 2024 American Association for the Study of Liver Diseases.